137 related articles for article (PubMed ID: 3390495)
21. Low platelet monoamine oxidase activity in borderline personality disorder.
Yehuda R; Southwick SM; Edell WS; Giller EL
Psychiatry Res; 1989 Dec; 30(3):265-73. PubMed ID: 2616692
[TBL] [Abstract][Full Text] [Related]
22. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.
Biederman J; Rivinus TM; Herzog DB; Ferber RA; Harper GP; Orsulak PJ; Harmatz JS; Schildkraut JJ
Am J Psychiatry; 1984 Oct; 141(10):1244-7. PubMed ID: 6486260
[TBL] [Abstract][Full Text] [Related]
23. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.
Samson JA; Gudeman JE; Schatzberg AF; Kizuka PP; Orsulak PJ; Cole JO; Schildkraut JJ
J Psychiatr Res; 1985; 19(4):547-55. PubMed ID: 4078757
[TBL] [Abstract][Full Text] [Related]
24. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
Poirier MF; Lôo H; Lefur G; Mitrani N
Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
[TBL] [Abstract][Full Text] [Related]
25. Platelet MAO activity in geriatric patients with depression and dementia.
Alexopoulos GS; Young RC; Lieberman KW; Shamoian CA
Am J Psychiatry; 1987 Nov; 144(11):1480-3. PubMed ID: 3674232
[TBL] [Abstract][Full Text] [Related]
26. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
[TBL] [Abstract][Full Text] [Related]
27. Platelet MAO-B activity in anxiety and depression.
Khan A; Lee E; Dager S; Hyde T; Raisys V; Avery D; Dunner D
Biol Psychiatry; 1986 Jul; 21(8-9):847-9. PubMed ID: 3730465
[No Abstract] [Full Text] [Related]
28. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
Zhou DF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
[No Abstract] [Full Text] [Related]
29. The dexamethasone suppression test in relation to symptomatology: preliminary findings controlling for serum dexamethasone concentrations.
Smith J; Carr V; Morris H; Gilliland J
Psychiatry Res; 1988 Aug; 25(2):123-33. PubMed ID: 3174902
[TBL] [Abstract][Full Text] [Related]
30. The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females.
Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Scharpe S; Blockx P
Biol Psychiatry; 1990 Mar; 27(6):601-8. PubMed ID: 2322619
[TBL] [Abstract][Full Text] [Related]
31. Life events and biological vulnerability: a study of life events and platelet MAO activity in depressed patients.
Perris H; von Knorring L; Oreland L; Perris C
Psychiatry Res; 1984 Jun; 12(2):111-20. PubMed ID: 6591218
[TBL] [Abstract][Full Text] [Related]
32. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
Rihmer Z; Arató M; Bagdy G
Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
[TBL] [Abstract][Full Text] [Related]
33. Pain as a symptom in depressive disorders and its relationship to platelet monoamine oxidase activity.
von Knorring L; Perris C; Oreland L; Eisemann M; Eriksson U; Perris H
J Neural Transm; 1984; 60(1):1-9. PubMed ID: 6207267
[TBL] [Abstract][Full Text] [Related]
34. Psychiatric morbidity and platelet monoamine oxidase activity in cancer patients.
Prasad A; Rampling RP; Glover V; Sandler M
Psychiatry Res; 1987 Oct; 22(2):111-6. PubMed ID: 3685221
[TBL] [Abstract][Full Text] [Related]
35. Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatment.
Moriearty PL; Herrick C; Shafey M; Bornstein P; Becker RE
Biol Psychiatry; 1987 Sep; 22(9):1155-8. PubMed ID: 3651533
[No Abstract] [Full Text] [Related]
36. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
Acta Psychiatr Scand; 1990 Apr; 81(4):364-71. PubMed ID: 2343764
[TBL] [Abstract][Full Text] [Related]
37. Platelet markers of suicidality.
Meltzer HY; Arora RC
Ann N Y Acad Sci; 1986; 487():271-80. PubMed ID: 3471162
[TBL] [Abstract][Full Text] [Related]
38. MAO-B activity in depression and anxiety disorders.
Sofuoğlu S; Doğan P; Besim T; Baştürk M; Tanrikulu G
Biol Psychiatry; 1992 Mar; 31(6):634-8. PubMed ID: 1581446
[No Abstract] [Full Text] [Related]
39. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder.
Lahmeyer HW; Val E; Gaviria FM; Prasad RB; Pandey GN; Rodgers P; Weiler MA; Altman EG
Psychiatry Res; 1988 Jul; 25(1):19-30. PubMed ID: 3217463
[TBL] [Abstract][Full Text] [Related]
40. Cortisol nonsuppression in depression: relationship to clinical variables.
Roy A
J Affect Disord; 1988; 14(3):265-70. PubMed ID: 2968388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
